论文部分内容阅读
目的探讨妈咪爱和思密达联合用药治疗婴儿轮状病毒肠炎的临床疗效。方法选择2009年6月～2010年6月某院收治的轮状病毒肠炎患儿60例,按随机数字表法分为观察组和对照组,每组30例。对照组给予常规治疗,观察组在此基础上给予妈咪爱和思密达联合用药。观察两组的临床疗效、症状改善和不良反应。结果观察组临床疗效总有效率为93.3%(28/30),对照组为66.7%(20/30),差异有统计学意义(P﹤0.01);观察组患儿的脱水恢复时间、止泻时间及住院时间均明显早于对照组,差异均有统计学意义(P﹤0.05);两组均未出现明显不良反应。结论妈咪爱和思密达联合应用治疗婴儿轮状病毒肠炎能产生协同作用,既能维持肠道微生态平衡又能保护肠黏膜,从而迅速改善症状,显著提高疗效,值得临床进一步推广和应用。
Objective To investigate the clinical efficacy of combination of mommy and smecta in the treatment of infantile rotavirus enteritis. Methods Sixty children with rotavirus enteritis admitted in a hospital from June 2009 to June 2010 were divided into observation group and control group according to random number table method, with 30 cases in each group. The control group given conventional treatment, the observation group on the basis of mommy love and smecta combination therapy. The clinical efficacy, symptom improvement and adverse reactions in both groups were observed. Results The total effective rate was 93.3% (28/30) in the observation group and 66.7% (20/30) in the control group, the difference was statistically significant (P <0.01). The recovery time, Time and hospitalization were significantly earlier than the control group, the difference was statistically significant (P <0.05); no significant adverse reactions in both groups. Conclusion Mami Ai and Smecta combined application of treatment of infantile rotavirus enteritis can produce synergies, both to maintain intestinal microflora balance and to protect the intestinal mucosa, thereby rapidly improving the symptoms and significantly improve the efficacy, it is worth further clinical application and application .